An important and recently published study funded primarily by the National Cancer Institute suggest that current screening for ovarian cancer fails to detect the disease in its early stage.
Methodology under review was screening with transvaginal ultrasound (TVU) and serum biomarker CA 125. The majority of Ovarian Cancers identified were at late stage (III or IV). At this stage, treatment options are limited and chance of cure is substituted with palliative treatment measures. Unfortunately current annual screening also was cited with false positive test results which lead to unnecessary surgeries in otherwise healthy patients.
Clearly better and more reliable screening is required to reduce the high rate of mortality associated with Ovarian Cancer and it’s late diagnosis. An abstract of the study is currently available in: Obstet Gynecol. 2009:113:772-774, 775-782.
posted by David Marc Schwadron, Esq.
Become a Fan of the Lewis Law Firm on Facebook
[...] studies to that previously mentioned here in this blog http://www.medicalmalpracticelawyerblogphiladelphia.com/?p=21 support the notion that Ovarian Cancer is problematic for clinicians and patients alike. The [...]